In order to confirm the expression of ATAD2 in various tumors [11, 16–19], we performed immunohistochemistry analysis on tissue microarrays (TMA) from multiple cancer types including breast, prostate, gastric, colorectal and lung cancers (Figures 1A and Supplementary Figure S1A). The gene discussed is ATAD2; the disease is cancer.